Hemostasis is a dynamic extremely complicated process that involves many interacting components. As a result, during activation no factor remains static or works in isolation. The TEG® system is unique in its ability to detect the state, cause, and the extent of imbalance in patient hemostasis and in providing guidance to effective treatment.
Our years of experience with the TEG® system and its clinical application and our relationships with eminent hemostasis experts, together our vision of how we can contribute to improved, easier, and faster hemostasis monitoring provide a unique advantage to us, our customers, and their patients in delivering clinical tools that are not only state of the art, but are ahead of their time.
For over 25 years, Haemoscope has consistently made advancements in the original TEG® hemostasis analyzer and now produces the gold standard in hemostasis monitoring and blood product management. We continue to earn our leadership position in this field each day with enhancements to our products, our support policies, and our commitment to improved patient care.
Accurate diagnosis leads to proper treatment and appropriate use of blood products and pharmaceuticals. Specifically, TEG® analysis:
![]() |
||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||
![]() |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
| Haemonetics Corp. | Sales Contacts
| Contact Us | Feedback | Events
COPYRIGHT © 1998-2007 Haemoscope Corporation. All rights reserved. |
||||||||||||||||||||||||||